Position in RCUS
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$8,937,604
-$773,429 QoQ
Shares Held
413,778
+1.5% QoQ
Ownership
0.329%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. RCUS ranks #36 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in RCUS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,937,604 | 413,778 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $9,711,033 | 407,513 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $4,549,526 | 334,524 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,736,870 | 336,225 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,629,600 | 334,981 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $3,923,767 | 263,517 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $3,908,292 | 255,611 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $4,178,928 | 274,388 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $5,474,538 | 289,965 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $6,356,746 | 332,814 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $5,913,483 | 329,442 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $6,664,319 | 328,130 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $5,923,256 | 324,740 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $6,803,864 | 329,007 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $8,925,948 | 341,206 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $8,407,228 | 331,777 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $262,326 | 8,312 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $347,232 | 8,580 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $490,934 | 14,079 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $449,300 | 16,362 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $625,116 | 24,080 | Shares | Defined | 2021-02-23 | |
| No filing history on record for this holder in this stock. | ||||||